Privi Liabilities And Stockholders Equity from 2010 to 2024

PRIVISCL   1,909  66.80  3.63%   
Privi Speciality's Liabilities And Stockholders Equity is increasing over the years with slightly volatile fluctuation. Overall, Liabilities And Stockholders Equity is expected to go to about 24.6 B this year. Liabilities And Stockholders Equity is the total of all liabilities and equity in the company, which should equal Privi Speciality's total assets according to the accounting equation. View All Fundamentals
 
Liabilities And Stockholders Equity  
First Reported
2012-03-31
Previous Quarter
9.4 B
Current Value
24.6 B
Quarterly Volatility
7.7 B
 
Yuan Drop
 
Covid
Check Privi Speciality financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Privi Speciality's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 B, Interest Expense of 1.1 B or Total Revenue of 18.4 B, as well as many indicators such as . Privi financial statements analysis is a perfect complement when working with Privi Speciality Valuation or Volatility modules.
  
This module can also supplement various Privi Speciality Technical models . Check out the analysis of Privi Speciality Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Privi Stock

Privi Speciality financial ratios help investors to determine whether Privi Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Privi with respect to the benefits of owning Privi Speciality security.